{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T19:56:14Z","timestamp":1785786974863,"version":"3.56.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2023,12,29]],"date-time":"2023-12-29T00:00:00Z","timestamp":1703808000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,12,29]],"date-time":"2023-12-29T00:00:00Z","timestamp":1703808000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100005294","name":"Massachusetts General Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005294","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1007\/s00259-023-06567-9","type":"journal-article","created":{"date-parts":[[2023,12,29]],"date-time":"2023-12-29T01:02:20Z","timestamp":1703811740000},"page":"1506-1515","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["MIDOS: a novel stochastic model towards a treatment planning system for microsphere dosimetry in liver tumors"],"prefix":"10.1007","volume":"51","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2290-0176","authenticated-orcid":false,"given":"Carlos","family":"Huesa-Berral","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6265-3355","authenticated-orcid":false,"given":"Julia D.","family":"Withrow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0984-4088","authenticated-orcid":false,"given":"Robert J.","family":"Dawson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0061-5473","authenticated-orcid":false,"given":"Chris","family":"Beekman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7175-9968","authenticated-orcid":false,"given":"Wesley E.","family":"Bolch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6257-2413","authenticated-orcid":false,"given":"Harald","family":"Paganetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4712-3986","authenticated-orcid":false,"given":"Eric","family":"Wehrenberg-Klee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9890-693X","authenticated-orcid":false,"given":"Alejandro","family":"Bertolet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,12,29]]},"reference":[{"key":"6567_CR1","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s40658-018-0221-z","volume":"5","author":"R Bastiaannet","year":"2018","unstructured":"Bastiaannet R, Kappadath SC, Kunnen B, Braat AJAT, Lam MGEH, de Jong HWAM. The physics of radioembolization. EJNMMI Phys. 2018;5:22.","journal-title":"EJNMMI Phys."},{"key":"6567_CR2","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.ejmp.2019.09.236","volume":"68","author":"SP Kim","year":"2019","unstructured":"Kim SP, Cohalan C, Kopek N, Enger SA. A guide to 90Y radioembolization and its dosimetry. Phys Med. 2019;68:132\u201345.","journal-title":"Phys Med"},{"key":"6567_CR3","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1053\/j.semnuclmed.2021.12.009","volume":"52","author":"SA Gulec","year":"2022","unstructured":"Gulec SA, McGoron AJ. Radiomicrosphere dosimetry: principles and current state of the art. Semin Nucl Med. 2022;52:215\u201328.","journal-title":"Semin Nucl Med"},{"key":"6567_CR4","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1016\/j.jvir.2023.03.011","volume":"34","author":"GM Knight","year":"2023","unstructured":"Knight GM, Gordon AC, Gates V, Talwar A, Riaz A, Salem R, et al. Evolution of personalized dosimetry for radioembolization of hepatocellular carcinoma. J Vasc Interv Radiol. 2023;34:1214\u201325.","journal-title":"J Vasc Interv Radiol."},{"key":"6567_CR5","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1016\/j.ijrobp.2005.12.051","volume":"65","author":"AS Kennedy","year":"2006","unstructured":"Kennedy AS, Coldwell D, Nutting C, Murthy R, Wertman DE, Loehr SP, et al. Resin 90Y-microsphere brachytherapy for unresectable colorectal liver metastases: modern USA experience. Int J Radiat Oncol Biol Phys. 2006;65:412\u201325.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"6567_CR6","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1053\/j.tvir.2019.02.003","volume":"22","author":"A Malhotra","year":"2019","unstructured":"Malhotra A, Liu DM, Talenfeld AD. Radiation segmentectomy and radiation lobectomy: a practical review of techniques. Tech Vasc Interv Radiol. 2019;22:49\u201357.","journal-title":"Tech Vasc Interv Radiol"},{"key":"6567_CR7","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.adro.2016.08.003","volume":"1","author":"MA Westcott","year":"2016","unstructured":"Westcott MA, Coldwell DM, Liu DM, Zikria JF. The development, commercialization, and clinical context of yttrium-90 radiolabeled resin and glass microspheres. Adv Radiat Oncol. 2016;1:351\u201364.","journal-title":"Adv Radiat Oncol"},{"key":"6567_CR8","doi-asserted-by":"publisher","first-page":"1682","DOI":"10.1007\/s00259-021-05600-z","volume":"49","author":"M Weber","year":"2022","unstructured":"Weber M, Lam M, Chiesa C, Konijnenberg M, Cremonesi M, Flamen P, et al. EANM procedure guideline for the treatment of liver cancer and liver metastases with intra-arterial radioactive compounds. Eur J Nucl Med Mol Imaging. 2022;49:1682\u201399.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"6567_CR9","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1053\/j.semnuclmed.2019.01.008","volume":"49","author":"MTM Reinders","year":"2019","unstructured":"Reinders MTM, Smits MLJ, van Roekel C, Braat AJAT. Holmium-166 microsphere radioembolization of hepatic malignancies. Semin Nucl Med. 2019;49:237\u201343.","journal-title":"Semin Nucl Med"},{"key":"6567_CR10","doi-asserted-by":"publisher","first-page":"1654","DOI":"10.2967\/jnumed.115.162685","volume":"56","author":"H Ilhan","year":"2015","unstructured":"Ilhan H, Goritschan A, Paprottka P, Jakobs TF, Fendler WP, Todica A, et al. Predictive value of 99mTc-MAA SPECT for 90Y-labeled resin microsphere distribution in radioembolization of primary and secondary hepatic tumors. J Nucl Med. 2015;56:1654\u201360.","journal-title":"J Nucl Med"},{"key":"6567_CR11","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1016\/j.jvir.2016.12.1221","volume":"28","author":"P Haste","year":"2017","unstructured":"Haste P, Tann M, Persohn S, LaRoche T, Aaron V, Mauxion T, et al. Correlation of technetium-99m macroaggregated albumin and yttrium-90 glass microsphere biodistribution in hepatocellular carcinoma: a retrospective review of pretreatment single photon emission CT and posttreatment positron emission tomography\/CT. J Vasc Interv Radiol. 2017;28:722-730.e1.","journal-title":"J Vasc Interv Radiol"},{"key":"6567_CR12","doi-asserted-by":"publisher","first-page":"244002","DOI":"10.1088\/1361-6560\/ac43fd","volume":"66","author":"A Bertolet","year":"2021","unstructured":"Bertolet A, Wehrenberg-Klee E, Bobic M, Grassberger C, Perl J, Paganetti H, et al. Pre- and post-treatment image-based dosimetry in 90Y-microsphere radioembolization using the TOPAS Monte Carlo toolkit. Phys Med Biol. 2021;66:244002.","journal-title":"Phys Med Biol"},{"key":"6567_CR13","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1016\/j.jvir.2020.12.023","volume":"32","author":"A Villalobos","year":"2021","unstructured":"Villalobos A, Cheng B, Wagstaff W, Sethi I, Bercu Z, Schuster DM, et al. Tumor-to-normal ratio relationship between planning technetium-99 macroaggregated albumin and posttherapy yttrium-90 bremsstrahlung SPECT\/CT. J Vasc Interv Radiol. 2021;32:752\u201360.","journal-title":"J Vasc Interv Radiol"},{"key":"6567_CR14","doi-asserted-by":"publisher","first-page":"4160","DOI":"10.1007\/s00330-021-08501-9","volume":"32","author":"S Young","year":"2022","unstructured":"Young S, Chen T, Flanagan S, Golzarian J, Sanghvi T. Realized tumor to normal ratios in hepatocellular carcinoma patients undergoing transarterial radioembolization: a retrospective evaluation. Eur Radiol. 2022;32:4160\u20137.","journal-title":"Eur Radiol"},{"key":"6567_CR15","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1016\/j.jvir.2023.02.030","volume":"34","author":"A Villalobos","year":"2023","unstructured":"Villalobos A, Arndt L, Cheng B, Dabbous H, Loya M, Majdalany B, et al. Yttrium-90 radiation segmentectomy of hepatocellular carcinoma: a comparative study of the effectiveness, safety, and dosimetry of glass vs. resin-based microspheres. J Vasc Interv Radiol. 2023;34:1226\u201334.","journal-title":"J Vasc Interv Radiol"},{"key":"6567_CR16","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1007\/s00259-019-04588-x","volume":"47","author":"AS Pasciak","year":"2020","unstructured":"Pasciak AS, Abiola G, Liddell RP, Crookston N, Besharati S, Donahue D, et al. The number of microspheres in Y90 radioembolization directly affects normal tissue radiation exposure. Eur J Nucl Med Mol Imaging. 2020;47:816\u201327.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"6567_CR17","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1007\/s00270-022-03139-6","volume":"45","author":"AWP Maxwell","year":"2022","unstructured":"Maxwell AWP, Mendoza HG, Sellitti MJ, Camacho JC, Deipolyi AR, Ziv E, et al. Optimizing 90Y particle density improves outcomes after radioembolization. Cardiovasc Intervent Radiol. 2022;45:958\u201369.","journal-title":"Cardiovasc Intervent Radiol"},{"key":"6567_CR18","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1016\/j.jvir.2023.03.005","volume":"34","author":"FE Boas","year":"2023","unstructured":"Boas FE, Maxwell AWP. Beyond mean tumor dose: the importance of particle density in radioembolization. J Vasc Interv Radiol. 2023;34:1235\u20136.","journal-title":"J Vasc Interv Radiol."},{"key":"6567_CR19","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1007\/s00270-021-02956-5","volume":"45","author":"J Aramburu","year":"2022","unstructured":"Aramburu J, Ant\u00f3n R, Rodr\u00edguez-Fraile M, Sangro B, Bilbao JI. Computational fluid dynamics modeling of liver radioembolization: a review. Cardiovasc Intervent Radiol Springer. 2022;45:12\u201320.","journal-title":"Cardiovasc Intervent Radiol. Springer"},{"key":"6567_CR20","doi-asserted-by":"crossref","unstructured":"Toskich B, Lewandowski RJ. Computational modeling of radioembolization: how to calculate infinity. Cardiovasc Intervent Radiol. Springer; 2021. pp. 2020\u20131.","DOI":"10.1007\/s00270-021-02989-w"},{"key":"6567_CR21","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.jvir.2022.07.032","volume":"34","author":"SR Miller","year":"2023","unstructured":"Miller SR, Jernigan SR, Abraham RJ, Buckner GD. Comparison of bolus versus dual-syringe administration systems on glass yttrium-90 microsphere deposition in an in vitro microvascular hepatic tumor model. J Vasc Interv Radiol. 2023;34:11\u201320.","journal-title":"J Vasc Interv Radiol"},{"key":"6567_CR22","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1109\/TRPMS.2018.2842463","volume":"3","author":"NR Crookston","year":"2019","unstructured":"Crookston NR, Fung GSK, Frey EC. Development of a customizable hepatic arterial tree and particle transport model for use in treatment planning. IEEE Trans Radiat Plasma Med Sci. 2019;3:31\u20137.","journal-title":"IEEE Trans Radiat Plasma Med Sci"},{"key":"6567_CR23","doi-asserted-by":"publisher","first-page":"135","DOI":"10.2967\/jnumed.113.126839","volume":"55","author":"S Walrand","year":"2014","unstructured":"Walrand S, Hesse M, Chiesa C, Lhommel R, Jamar F. The low hepatic toxicity per gray of 90Y glass microspheres is linked to their transport in the arterial tree favoring a nonuniform trapping as observed in posttherapy PET imaging. J Nucl Med. 2014;55:135\u201340.","journal-title":"J Nucl Med"},{"key":"6567_CR24","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1016\/j.ijrobp.2016.05.007","volume":"96","author":"J H\u00f6gberg","year":"2016","unstructured":"H\u00f6gberg J, Rizell M, Hultborn R, Svensson J, Henrikson O, M\u00f6lne J, et al. Simulation model of microsphere distribution for selective internal radiation therapy agrees with observations. Int J Radiat Oncol Biol Phys. 2016;96:414\u201321.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"6567_CR25","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.2967\/jnumed.115.163444","volume":"57","author":"AS Pasciak","year":"2016","unstructured":"Pasciak AS, Bourgeois AC, Bradley YC. A microdosimetric analysis of absorbed dose to tumor as a function of number of microspheres per unit volume in 90Y Radioembolization. J Nucl Med. 2016;57:1020\u20136.","journal-title":"J Nucl Med"},{"key":"6567_CR26","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s40658-022-00456-0","volume":"9","author":"CM Correa-Alfonso","year":"2022","unstructured":"Correa-Alfonso CM, Withrow JD, Domal SJ, Xing S, Shin J, Grassberger C, et al. A mesh-based model of liver vasculature: implications for improved radiation dosimetry to liver parenchyma for radiopharmaceuticals. EJNMMI Phys. 2022;9:28.","journal-title":"EJNMMI Phys."},{"key":"6567_CR27","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1007\/s00259-013-2575-8","volume":"41","author":"RJ Lewandowski","year":"2014","unstructured":"Lewandowski RJ, Minocha J, Memon K, Riaz A, Gates VL, Ryu RK, et al. Sustained safety and efficacy of extended-shelf-life 90Y glass microspheres: long-term follow-up in a 134-patient cohort. Eur J Nucl Med Mol Imaging. 2014;41:486\u201393.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"6567_CR28","unstructured":"Gulec SA, Mesoloras G, Stabin M. Dosimetric techniques in 90 Y-microsphere therapy of liver cancer: the MIRD equations for dose calculations. J Nucl Med. 2006;47."},{"key":"6567_CR29","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1088\/0031-9155\/45\/4\/316","volume":"45","author":"AM Campbell","year":"2000","unstructured":"Campbell AM, Bailey IH, Burton MA. Analysis of the distribution of intra-arterial microspheres in human liver following hepatic yttrium-90 microsphere therapy. Phys Med Biol. 2000;45:1023\u201333.","journal-title":"Phys Med Biol"},{"key":"6567_CR30","doi-asserted-by":"crossref","unstructured":"H\u00f6gberg J, Rizell M, Hultborn R, Svensson J, Henrikson O, M\u00f6lne J, et al. Heterogeneity of microsphere distribution in resected liver and tumour tissue following selective intrahepatic radiotherapy. EJNMMI Res. 2014;4.","DOI":"10.1186\/s13550-014-0048-0"},{"key":"6567_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40658-015-0113-4","volume":"2","author":"J H\u00f6gberg","year":"2015","unstructured":"H\u00f6gberg J, Rizell M, Hultborn R, Svensson J, Henrikson O, M\u00f6lne J, et al. Increased absorbed liver dose in selective internal radiation therapy (SIRT) correlates with increased sphere-cluster frequency and absorbed dose inhomogeneity. EJNMMI Phys. 2015;2:1\u201317.","journal-title":"EJNMMI Phys"},{"key":"6567_CR32","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.1016\/j.ijrobp.2004.09.004","volume":"60","author":"AS Kennedy","year":"2004","unstructured":"Kennedy AS, Nutting C, Coldwell D, Gaiser J, Drachenberg C. Pathologic response and microdosimetry of 90Y microspheres in man: review of four explanted whole livers. Int J Radiat Oncol Biol Phys. 2004;60:1552\u201363.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"6567_CR33","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1053\/j.tvir.2019.02.004","volume":"22","author":"BJ Schiro","year":"2019","unstructured":"Schiro BJ, Amour ES, Harnain C, Gandhi RT. Management of high hepatopulmonary shunts in the setting of Y90 radioembolization. Tech Vasc Interv Radiol. 2019;22:58\u201362.","journal-title":"Tech Vasc Interv Radiol"},{"key":"6567_CR34","doi-asserted-by":"crossref","unstructured":"Riaz A, Awais R, Salem R. Side effects of yttrium-90 radioembolization. Front Oncol. 2014;4.","DOI":"10.3389\/fonc.2014.00198"},{"key":"6567_CR35","doi-asserted-by":"publisher","first-page":"1658","DOI":"10.1007\/s00259-020-05079-0","volume":"48","author":"C Van Roekel","year":"2021","unstructured":"Van Roekel C, Van Den Hoven AF, Bastiaannet R, Bruijnen RCG, Braat AJAT, De Keizer B, et al. Use of an anti-reflux catheter to improve tumor targeting for holmium-166 radioembolization-a prospective, within-patient randomized study. Eur J Nucl Med Mol Imaging. 2021;48:1658\u201368.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"6567_CR36","doi-asserted-by":"publisher","first-page":"1891","DOI":"10.2967\/jnumed.122.263823","volume":"63","author":"MTM Reinders","year":"2022","unstructured":"Reinders MTM, van Erpecum KJ, Smits MLJ, Braat AJAT, de Bruijne J, Bruijnen R, et al. Safety and efficacy of 166Ho radioembolization in hepatocellular carcinoma: the HEPAR Primary Study. J Nucl Med. 2022;63:1891\u20138.","journal-title":"J Nucl Med"},{"key":"6567_CR37","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1016\/j.jvir.2020.01.032","volume":"31","author":"C van Roekel","year":"2020","unstructured":"van Roekel C, Harlianto NI, Braat AJAT, Prince JF, van den Hoven AF, Bruijnen RCG, et al. Evaluation of the safety and feasibility of same-day holmium-166-radioembolization simulation and treatment of hepatic metastases. J Vasc Interv Radiol. 2020;31:1593\u20139.","journal-title":"J Vasc Interv Radiol"},{"key":"6567_CR38","doi-asserted-by":"publisher","first-page":"3705","DOI":"10.1016\/j.jbiomech.2016.09.035","volume":"49","author":"J Aramburu","year":"2016","unstructured":"Aramburu J, Ant\u00f3n R, Rivas A, Ramos JC, Sangro B, Bilbao JI. Computational assessment of the effects of the catheter type on particle\u2013hemodynamics during liver radioembolization. J Biomech. 2016;49:3705\u201313.","journal-title":"J Biomech"},{"key":"6567_CR39","doi-asserted-by":"publisher","first-page":"4280","DOI":"10.3390\/math10224280","volume":"10","author":"U Lertxundi","year":"2022","unstructured":"Lertxundi U, Aramburu J, Rodr\u00edguez-Fraile M, Sangro B, Ant\u00f3n R. Computational study of the microsphere concentration in blood during radioembolization. Mathematics. 2022;10:4280.","journal-title":"Mathematics."},{"key":"6567_CR40","doi-asserted-by":"publisher","first-page":"e2895","DOI":"10.1002\/cnm.2895","volume":"33","author":"J Aramburu","year":"2017","unstructured":"Aramburu J, Ant\u00f3n R, Rivas A, Ramos JC, Sangro B, Bilbao JI. The role of angled-tip microcatheter and microsphere injection velocity in liver radioembolization: a computational particle\u2013hemodynamics study. Int J Numer Method Biomed Eng. 2017;33:e2895.","journal-title":"Int J Numer Method Biomed Eng."},{"key":"6567_CR41","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1016\/j.jvir.2022.03.006","volume":"33","author":"A Taebi","year":"2022","unstructured":"Taebi A, Janibek N, Goldman R, Pillai R, Vu CT, Roncali E. The impact of injection distance to bifurcations on yttrium-90 distribution in liver cancer radioembolization. J Vasc Interv Radiol. 2022;33:668\u201377.","journal-title":"J Vasc Interv Radiol"},{"key":"6567_CR42","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1080\/17425247.2021.1853702","volume":"18","author":"T Bomberna","year":"2021","unstructured":"Bomberna T, Koudehi GA, Claerebout C, Verslype C, Maleux G, Debbaut C. Transarterial drug delivery for liver cancer: numerical simulations and experimental validation of particle distribution in patient-specific livers. Expert Opin Drug Deliv. 2021;18:409\u201322.","journal-title":"Expert Opin Drug Deliv"}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-023-06567-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00259-023-06567-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-023-06567-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,24]],"date-time":"2024-04-24T06:03:59Z","timestamp":1713938639000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00259-023-06567-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,29]]},"references-count":42,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["6567"],"URL":"https:\/\/doi.org\/10.1007\/s00259-023-06567-9","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,29]]},"assertion":[{"value":"24 August 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 December 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 December 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Eric Wehrenberg-Klee reports consulting fees from SIRTEX, Embolx, Avenge Biosciences, and Cytosite Bio. He has served on advisory boards for Delcath and Eisai. He is an IDMC member for Replimune. He receives clinical research funding from Boston Scientific. He is grant funded by NCI K08-245257.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}